Investing.com - ANI Pharma reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
ANI Pharma announced earnings per share of $0.64 on revenue of $83.8M. Analysts polled by Investing.com anticipated EPS of $0.53 on revenue of $77.2M.
ANI Pharma shares are down 16.73% from the beginning of the year, still down 24.47% from its 52 week high of $51.69 set on December 23, 2021.
ANI Pharma shares lost 2.00% in pre-market trade following the report.
ANI Pharma follows other major Healthcare sector earnings this month
ANI Pharma's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar